Bottom line
PRHSX vs AHSZX: the short answer
PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and AHSZX (Alger Health Sciences Fund) are quite different portfolios: only about 34% of their top holdings (by weight) are shared.
But PRHSX is far broader, holding 279 positions to 55 for AHSZX, so beyond the top names it adds exposure AHSZX doesn't have.
AHSZX is cheaper at 0.76% vs 0.83% — a difference of $7.00 a year per $10,000 invested.
Over five years, PRHSX returned +4.2% a year vs −1.6% for AHSZX.
Updated Nov 19, 2026
PRHSX vs AHSZX side by side
| PRHSX | AHSZX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | T. Rowe Price | Alger |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.83% | 0.76% |
| Annual cost per $10k | $83 | $76 |
| 10-yr cost on $10k (prospectus) | $1,025 | $1,004 |
| Max front load | — | — |
| 12b-1 fee | — | 0% |
| 1-yr return | +17.7% | +10.6% |
| 5-yr return (annualized) | +4.2% | −1.6% |
| 10-yr return (annualized) | +9.1% | +7.8% |
| Best quarter | +23.5% | +24.6% |
| Worst quarter | −15.8% | −18.6% |
| Net assets (fund) | $11.9B | $75.4M |
| Number of holdings | 279 | 55 |
| Portfolio turnover | 62% | 289% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | PRHSX | AHSZX | Difference |
|---|---|---|---|
| 2025 | +17.7% | +10.6% | +7.1% |
| 2024 | +1.8% | +1.6% | +0.2% |
| 2023 | +3.1% | −3.9% | +7.0% |
| 2022 | −12.2% | −16.7% | +4.6% |
| 2021 | +13.3% | +2.8% | +10.5% |
| 2020 | +30.1% | +31.5% | −1.3% |
| 2019 | +29.1% | +22.4% | +6.7% |
| 2018 | +1.2% | +6.2% | −4.9% |
| 2017 | +28.0% | +37.7% | −9.8% |
| 2016 | −10.4% | −2.9% | −7.5% |
Source: Fund prospectus bar charts
Holdings overlap
9 of PRHSX's top 25 holdings also appear in AHSZX's top 25.
| Holding | PRHSX | AHSZX |
|---|---|---|
| Eli Lilly & Co | 14.28% | 3.29% |
| Johnson & Johnson | 6.63% | 4.06% |
| Unitedhealth Group Inc | 5.99% | 3.61% |
| Merck & Co. Inc. | 4.01% | 4.18% |
| Thermo Fisher Scientific Inc | 2.52% | 4.00% |
| Vertex Pharmaceuticals Inc | 2.28% | 1.80% |
| Abbott Laboratories | 1.89% | 2.93% |
| Guardant Health Inc | 1.23% | 1.81% |
| Cvs Health Corp | 0.94% | 3.67% |
Source: SEC Form N-PORT
PRHSX top 10
- Eli Lilly & Co — 14.28%
- Johnson & Johnson — 6.63%
- Unitedhealth Group Inc — 5.99%
- Abbvie Inc — 5.10%
- Merck & Co. Inc. — 4.01%
- Gilead Sciences Inc — 2.82%
- Thermo Fisher Scientific Inc — 2.52%
- Vertex Pharmaceuticals Inc — 2.28%
- Bristol-myers Squibb Co — 2.11%
- Abbott Laboratories — 1.89%
AHSZX top 10
- Dreyfus Treasury Obligations Cash Management — 6.51%
- Impulse Dynamics Ireland — 4.27%
- Merck & Company Inc — 4.18%
- Welltower Inc — 4.12%
- Johnson & Johnson — 4.06%
- Thermo Fisher Scientific Inc — 4.00%
- Bruker Corp — 3.98%
- Illumina Inc — 3.95%
- Cvs Health Corp — 3.67%
- Unitedhealth Group Inc — 3.61%
FAQ
What is the difference between PRHSX and AHSZX?
Which is cheaper, PRHSX or AHSZX?
Should I own both PRHSX and AHSZX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.